About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Cxcl16tm1Syon
targeted mutation 1, Shin Yonehara
MGI:4414661
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Cxcl16tm1Syon/Cxcl16tm1Syon B6.129P2-Cxcl16tm1Syon MGI:4414663


Genotype
MGI:4414663
hm1
Allelic
Composition
Cxcl16tm1Syon/Cxcl16tm1Syon
Genetic
Background
B6.129P2-Cxcl16tm1Syon
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Cxcl16tm1Syon mutation (0 available); any Cxcl16 mutation (23 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• in the liver
• but no decrease is seen in the thymus or spleen
• the increase in serum levels of IFN gamma in null mice in response to alpha-galactosylceramide injection was only 20% of that seen in wild-type mice
• the increase in serum levels of interleukin 4 in null mice in response to alpha-galactosylceramide injection was only 60% of that seen in wild-type mice.
• liver leukocytes when stimulated with alpha-galactosylceramide for 72 hours produce less IFN gamma
• normal secretion when co-cultured with wild-type APC
• decreased production by CD4 T-cells after exposure to heat killed Propionibacterium acnes
• liver leukocytes when stimulated with alpha-galactosylceramide for 72 hours produce less IL-4
• normal secretion when co-cultured with wild-type antigen-presenting cells
• expression data indicates absence of liver damage in response to LPS administration in Propionibacterium acnes primed

homeostasis/metabolism
• the increase in serum levels of IFN gamma in null mice in response to alpha-galactosylceramide injection was only 20% of that seen in wild-type mice
• the increase in serum levels of interleukin 4 in null mice in response to alpha-galactosylceramide injection was only 60% of that seen in wild-type mice.
• decreased inhibition of B16 melanoma cell growth by alpha-galactosylceramide treatment

neoplasm
• decreased inhibition of B16 melanoma cell growth by alpha-galactosylceramide treatment

hematopoietic system
• in the liver
• but no decrease is seen in the thymus or spleen





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory